Pfizer Recalling 3 Blood Pressure Medication Types Due To Cancer Concerns, FDA Says

Photo caption: Pfizer is recalling certain lots of blood pressure medications due to a nitrosamine, N-nitroso-quinapril, being present in quantities above Acceptable Daily Intake (ADI) levels. Photo credit: Henny Ray Abrams / AFP via Getty Images. Article by Bruce Y. Lee. Forbes – March 26, 2022.

In the words of The Weeknd, here we go…again. There is yet another recall of blood pressure medications due to unacceptable levels of a substance that may cause cancer. This time it’s Pfizer that’s doing the voluntary recalling. This recall includes six lots of Accuretic tablets, which Pfizer directly distributes. It also includes medications distributed by Greenstone: four lots of tablets combining quinapril hydrochloride (HCl) with hydrochlorothiazide and one lot of tablets combining quinapril with hydrochlorothiazide. And this time the carcinogenic culprit of concern is a nitrosamine impurity called N-nitroso-quinapril. […]

Click here to view original web page at www.forbes.com